There are several important findings from the clinical research study on Xanthigen.

• Xanthigen was well tolerated with no safety concerns.
• Xanthigen is effective in reducing body weight at a dose of 600mg/day (200mg tid). The majority of this weight loss was due to a loss of body fat. Also, the subjects on average had a reduced waistline when taking Xanthigen, but not when taking a placebo. Participants lost an average of 5.5 kg (NAFLD) and 4.9 kg (NFL) MORE THAN the placebo groups by the end of the study.
• Xanthigen is also effective at reducing the amount of fat in the liver, and this loss in liver fat precedes the weight loss in the rest of the body.
• Xanthigen caused a net increase in the subjects’ resting metabolic rate (resting energy expenditure - REE) which was statistically significant when compared with baseline REE and with placebo.

In short, Xanthigen improved several important health factors, thus inspiring the motto Healthy Weight, Healthy Liver, Healthy Body.
Learn more about the results of research on Xanthigen by clicking on the "Research Data" tab above.

Results published: Abidov M, Ramazanov Z, Seifulla R, Grachev S. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat. Diabetes Obes Metab. 2010 Jan;12(1):72-81.